Persistence and Adherence to ICS/LABA Drugs in UK Patients with Asthma: A Retrospective New-User Cohort Study

INTRODUCTION: Asthma is associated with significant economic burden. Inhaled corticosteroid and long-acting beta(2)-agonist (ICS/LABA) combination therapies are considered mainstays of treatment. We describe real-world use of ICS/LABAs by comparing treatment persistence and adherence among patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Parimi, Mounika, Svedsater, Henrik, Ann, Quratul, Gokhale, Mugdha, Gray, Christen M., Hinds, David, Nixon, Mark, Boxall, Naomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467428/
https://www.ncbi.nlm.nih.gov/pubmed/32361850
http://dx.doi.org/10.1007/s12325-020-01344-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467428/
https://www.ncbi.nlm.nih.gov/pubmed/32361850
http://dx.doi.org/10.1007/s12325-020-01344-8

Ejemplares similares